The University of Kansas Infectious Disease Assay Development Core (IDAD) helps researchers with assay development and high throughput screening technologies for identifying chemical probes against infectious disease targets. The overall goal of the IDAD core is to provide expertise, facilities and services that encompass primary and secondary assay design and development, assay optimization and validation, small and large -scale compound and peptide screening for whole organism/cell based or biochemical infectious disease targets. The activities and outcomes of the IDAD core efforts are expected to generate high quality pilot data for infectious disease assay development and screening. The datasets are are expected to expand the scope of basic infectious disease research, support publications and also enable investigators to develop competitive proposals in response to extramural funding opportunities.


One of 34 U.S. public institutions in the prestigious Association of American Universities
44 nationally ranked graduate programs.
—U.S. News & World Report
Top 50 nationwide for size of library collection.
—ALA
5th nationwide for service to veterans —"Best for Vets: Colleges," Military Times
KU Today